Chime Biologics Supports Mabgeek to Enter the U.S. Phase III Trials for MG-K10 ...Middle East

PR Newswire - News
Chime Biologics Supports Mabgeek to Enter the U.S. Phase III Trials for MG-K10

SHANGHAI, Feb. 21, 2025 /PRNewswire/ -- Chime Biologics, a leading global CDMO that enables its partners' success in biologics, today announced its continued collaboration with Mabgeek in advancing MG-K10, a potential Best-in-Class therapy, a novel IL-4Rα-targeting antibody drug for...

    Read More Details
    Finally We wish PressBee provided you with enough information of ( Chime Biologics Supports Mabgeek to Enter the U.S. Phase III Trials for MG-K10 )

    Apple Storegoogle play

    Also on site :



    Latest News